Trial intelligence / Profile preview

BCG Vaccination Scar Formation in Children Under Five

NCT03548233Unknown

Sponsor
Assiut University
Start
May 2021
Primary completion
Dec 2021
Modality
Vaccines & Immunotherapeutics
01

Overview

Open-label trial of bcg vaccine in Tuberculosis (TB), sponsored by Assiut University. Primary endpoints: Frequency of children without BCG scar at 1 year, Factors affecting BCG scar formation at 1 year and 1 more. Status: unknown.

02

Drugs

bcg vaccine
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on NCT03548233.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03548233.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call